Inventor · disambiguated record
Peter William Surman
Also filed as: SURMAN PETER · SURMAN PETER WILLIAM
11 granted patents·8 pending applications·43 citations·filing 2004–2024
87Inventor score
Files withDOUGLAS PHARMACEUTICALS LTD15SURMAN PETER WILLIAM2DOUGLAS PHARMACETICALS LTD1SURMAN PETER1
Top patents by PatentIndex Score
19 records- 0195US10441544B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2017·Granted Oct 15, 2019·15 cites·11 claims
- 0294US11045424B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2019·Granted Jun 29, 2021·9 cites·13 claims
- 0390US12090123B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2020·Granted Sep 17, 2024·3 cites·20 claims
- 0489US12128140B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2020·Granted Oct 29, 2024·2 cites·66 claims
- 0588US11471416B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACETICALS LTD·Filed 2020·Granted Oct 18, 2022·4 cites·24 claims
- 0687US11471415B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACEUTICALS LTD·Filed 2018·Granted Oct 18, 2022·6 cites·22 claims
- 0774US12472146B2Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2022·Granted Nov 18, 2025·0 cites·22 claims
- 0873US12350378B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACEUTICALS LTD·Filed 2022·Granted Jul 8, 2025·0 cites·21 claims
- 0969US12350379B2Extended release pharmaceutical formulation and methods of treatmentDOUGLAS PHARMACEUTICALS LTD·Filed 2022·Granted Jul 8, 2025·0 cites·23 claims
- 1064US2025049734A1Extended release pharmaceutical formulationDOUGLAS PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1161US2024189259A2Extended Release Pharmaceutical FormulationDOUGLAS PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1260US2025064816A1Pharmaceutical rectal suppository compositions of 6-thioguanine, methods of treatment and/or methods of manufacturingDOUGLAS PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1359US12414994B2Compositions comprising lopinavir and treatment of conditionsDOUGLAS PHARMACEUTICALS LTD·Filed 2020·Granted Sep 16, 2025·0 cites·19 claims
- 1458US2025213580A1Improved Thiopurine Formulation and Treatment MethodsDOUGLAS PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1557US8057811B2Stable clozapine suspension formulationSURMAN PETER WILLIAM·Filed 2004·Granted Nov 15, 2011·4 cites·19 claims
- 1648US2014234430A1Pharmaceutical methods and topical compositions containing acitretinDOUGLAS PHARMACEUTICALS LTD·Filed 2012·Application pending·0 cites
- 1744US2013089575A1Pharmaceutical methods and topical compositions containing acitretinSURMAN PETER·Filed 2012·Application pending·0 cites
- 1844US2023285287A1Pharmaceutical compositionsDOUGLAS PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1929US2012058993A1Stable Suspension FormulationSURMAN PETER WILLIAM·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter William Surman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →